adenocarcinoma

Showing NaN - NaN of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostatic Tumors, Adenocarcinoma Trial in United States (JNJ-69086420)

Recruiting
  • Prostatic Neoplasms
  • Adenocarcinoma
  • Duarte, California
  • +7 more
Aug 2, 2022

NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)

Terminated
  • Non-Small Cell Lung Cancer
  • +3 more
  • Tucson, Arizona
  • +34 more
Oct 11, 2021

Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma Trial in Chicago (Oxaliplatin, Docetaxel,

Recruiting
  • Pancreatic Adenocarcinoma
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Jun 7, 2021

Adenocarcinoma Trial in Chicago (Trastuzumab, ABT-806, Bemarituzumab)

Completed
  • Adenocarcinoma
  • Chicago, Illinois
    University of Chicago
Mar 15, 2021

Gastric Cancer, Adenocarcinoma Trial in Worldwide (biological, drug, other)

Completed
  • Gastric Cancer
  • Adenocarcinoma
  • ramucirumab
  • +2 more
  • Bakersfield, California
  • +160 more
Sep 10, 2019

Pancreatic Cancer, Adenocarcinoma, Pancreatic Tumors Trial in San Francisco, Chicago, Madison (FOLFIRINOX, IPI-926)

Completed
  • Pancreatic Cancer
  • +2 more
  • FOLFIRINOX, IPI-926
  • San Francisco, California
  • +2 more
Aug 7, 2017

Barrett Syndrome, Barrett's Syndrome, Barrett's Esophagus Trial in France, United Kingdom, United States (Standard endoscopic

Completed
  • Barrett Syndrome
  • +4 more
  • Standard endoscopic evaluation
  • pCLE guided evaluation
  • Jacksonville, Florida
  • +5 more
Mar 22, 2016

Adenocarcinoma, Tumors Trial in Worldwide (Torisel)

Completed
  • Adenocarcinoma
  • Neoplasms
  • Birmingham, Alabama
  • +29 more
Jan 4, 2013

Pancreatic Cancer, Adenocarcinoma Trial in United States (ARQ 501 in combination with gemcitabine)

Completed
  • Pancreatic Cancer
  • Adenocarcinoma
  • ARQ 501 in combination with gemcitabine
  • Mobile, Alabama
  • +14 more
Apr 28, 2009